Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Kedudukan dalam Saham
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Harga Saham
$8.03
Modal Pasaran
$6.31B
Perubahan (1 hari)
1.07%
Perubahan (1 tahun)
-8.04%
Negara
CN
Perdagangan Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategori
Healthcare
Hasil untuk Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Hasil pada Jun 2026 TTM: $720.60M
Menurut laporan kewangan terkini daripada Shenzhen New Industries Biomedical Engineering Co., Ltd., hasil semasa syarikat (TTM) ialah $720.60M. Pada tahun 2024, syarikat memperoleh hasil sebanyak $621.36M peningkatan berbanding hasil pada tahun 2023 iaitu $555.15M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Shenzhen New Industries Biomedical Engineering Co., Ltd. dari 2012 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $720.60M | 10.16% |
| 2025 | $654.16M | 5.28% |
| 2024 | $621.36M | 11.93% |
| 2023 | $555.15M | 25.68% |
| 2022 | $441.72M | 10.30% |
| 2021 | $400.48M | 19.19% |
| 2020 | $336.00M | 39.13% |
| 2019 | $241.49M | 20.06% |
| 2018 | $201.15M | 14.74% |
| 2017 | $175.30M | 31.94% |
| 2016 | $132.87M | 17.92% |
| 2015 | $112.67M | 27.99% |
| 2014 | $88.03M | 41.22% |
| 2013 | $62.34M | 50.62% |
| 2012 | $41.39M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $48.23B | 6,592.92% |
US
|
|
| $37.54B | 5,109.85% |
IE
|
|
| $25.84B | 3,485.50% |
US
|
|
| $21.00B | 2,813.69% |
US
|
|
| $26.02B | 3,510.62% |
DE
|
